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Abstract
Talins and kindlins bind to the integrin b3 cytoplasmic tail and both are required for effective activation of integrin aIIbb3
and resulting high-affinity ligand binding in platelets. However, binding of the talin head domain alone to b3 is sufficient to
activate purified integrin aIIbb3 in vitro. Since talin is localized to the cytoplasm of unstimulated platelets, its re-localization
to the plasma membrane and to the integrin is required for activation. Here we explored the mechanism whereby kindlins
function as integrin co-activators. To test whether kindlins regulate talin recruitment to plasma membranes and to aIIbb3,
full-length talin and kindlin recruitment to b3 was studied using a reconstructed CHO cell model system that recapitulates
agonist-induced aIIbb3 activation. Over-expression of kindlin-2, the endogenous kindlin isoform in CHO cells, promoted
PAR1-mediated and talin-dependent ligand binding. In contrast, shRNA knockdown of kindlin-2 inhibited ligand binding.
However, depletion of kindlin-2 by shRNA did not affect talin recruitment to the plasma membrane, as assessed by sub-
cellular fractionation, and neither over-expression of kindlins nor depletion of kindlin-2 affected talin interaction with aIIbb3
in living cells, as monitored by bimolecular fluorescence complementation. Furthermore, talin failed to promote kindlin-2
association with aIIbb3 in CHO cells. In addition, purified talin and kindlin-3, the kindlin isoform expressed in platelets, failed
to promote each other’s binding to the b3 cytoplasmic tail in vitro. Thus, kindlins do not promote initial talin recruitment to
aIIbb3, suggesting that they co-activate integrin through a mechanism independent of recruitment.
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Introduction
Integrins are heterodimeric, transmembrane ab adhesion
receptors responsible for cell-cell and cell-matrix interactions
during embryonic development, responses to injury, and patho-
logical processes including athero-thrombosis and neoplasia. In
mammalian cells, the ligand-binding affinity of many integrins can
be regulated by ‘‘inside-out’’ signals, leading to propagated
conformational changes across the plasma membrane that
increase ligand binding affinity [1]. Studies in vitro and in vivo
indicate that this form of integrin activation requires the binding of
talin to the cytoplasmic tail of the integrin b subunit [2]. In
unstimulated platelets, for example, talin is localized primarily to
the cytoplasm [3] where it is thought to be ‘‘auto-inhibited’’ by
virtue of the masking of an integrin-binding interface within the
FERM domain of the N-terminal talin head domain (THD) by a
region of the C-terminal talin rod domain [4,5,6]. Inside-out
signals are hypothesized to release talin auto-inhibition, enabling
recruitment of the protein to the plasma membrane where it can
then interact with integrin b tails. This results in reorganization of
the a and b subunit cytoplasmic and transmembrane domains and
integrin activation [2,7,8].
In platelets [9,10] where aIIbb3 is the most abundant integrin,
and in a CHO cell model system used to study aIIbb3 signaling
[11,12], some of the key intracellular signals involved in agonist-
dependent talin recruitment to aIIbb3 have been identified. These
include activation of the Rap1 GTPase, formation of a membrane-
associated Rap1-GTP/RIAM adapter complex, and interaction of
RIAM with talin [13]. At the molecular level, aIIbb3 activation
requires a series of interactions of the THD with the b3 tail,
including the strong interaction with membrane-distal b3 tail
residues centered at
744NPLY
747, and additional interactions with
membrane-proximal b3 tail residues and plasma membrane
phospholipids [14,15,16].
THD interaction with b3 is sufficient for aIIbb3 activation
when tested in the context of recombinant proteins and membrane
lipid nanodiscs [17]. However, aIIbb3 activation in platelets also
requires kindlin-3, a hematopoietic cell-selective member of the
kindlin family of adapter molecules [18,19], which includes
kindlin-1 and kindlin-2 [20,21]. Although tissue distribution of
the kindlins varies, all members of the family appear capable of
engaging integrin b tails in a manner distinct from talin. For
example, the interaction of aIIbb3 with kindlin-3 or kindlin-2,
which is normally expressed in CHO cells, requires b3 tail residues
(
756NITY
759) that are membrane-distal to the talin-binding
744NPLY
747 residues [20,21,22]. Importantly, kindlins alone
appear to be less efficient than THD for aIIbb3 activation
[22,23,24]. Thus, the precise relationships between talin and
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Furthermore, disruption of an agonist-induced signaling pathway
leading to talin function can result in severe defects in inside-out
integrin activation, as in the case of Rap1b deficiency in platelets
[9]. Conceivably, kindlin could function at one or more loci of this
signaling pathway (Figure 1).
Here we investigated whether kindlins influence talin recruit-
ment to aIIbb3, one of the hypotheses proposed to explain the
mechanism of kindlin function [2,20,21,25]. Using complementa-
ry approaches with intact cells and purified, recombinant proteins,
we establish that kindlins do not promote talin recruitment to
plasma membranes or to aIIbb3. Conversely, talin does not
promote the interaction of kindlins with aIIbb3. These results
indicate that kindlins might promote integrin activation by playing
a role in events other than initial talin recruitment to integrin
aIIbb3.
Methods
Reagents and plasmid vectors
SFLLRN, an agonist peptide specific for human PAR1 [26] and
antibody to the Flag epitope were from Sigma-Aldrich (St. Louis,
MO). Antibodies specific for the external portion of the IL2
receptor (7G7B6, ‘‘Tac’’), the human integrin b3 C-terminus (Rb
8275), aIIb (Rb2308), aIIbb3 (D57) and activated aIIbb3 (PAC-1)
have been described [27,28,29]. Antibodies to b-actin, talin and
calnexin were from Abcam (Cambridge, MA); antibody to the
HA-epitope from Covance (Princeton, NJ); antibody to RhoGDI
from Santa Cruz Biotechnology (Santa Cruz, CA); and antibodies
to GFP and the His6 tag from Clontech (Mountain View, CA).
Alexa Fluor-568, Alexa Fluor-647 and R-phycoerythrin-conjugat-
ed secondary reagents were from Invitrogen (Carlsbad, CA).
Kindlin-2-specific antibody was a gift from Dr. Cary Wu,
University of Pittsburgh, Pittsburgh, PA [24].
Plasmids encoding cDNAs for mouse talin1 [12], human PAR1
[30] and human kindlin-2 were sub-cloned into the pcDNA4/TO
tetracycline-inducible expression vector (Invitrogen, Carlsbad,
CA). Where indicated, GFP or DsRed (Clontech, Mountain
View, CA) was used as a transfection marker.
Cell culture and transfection
CHO-K1 [31], 293T [32] and NIH3T3 [33] cells were cultured
in Dulbecco’s Modification of Eagle’s Medium (Cellgro, Manassas,
VA) and supplemented with antibiotics, nonessential amino acids,
L-glutamine and 10% fetal bovine serum. For transient transfec-
tions, Lipofectamine (Invitrogen, Carlsbad, CA) was used
according to the manufacturer’s recommendations. To produce
stable cell lines, CHO cells were transfected with the appropriate
expression plasmids. Forty-eight hours later, antibiotics for
selection were added and cells were cultured for ,2 weeks.
Clones were selected further by single-cell sorting using MoFlo
(Dako, Carpinteria, CA) and stable expression of recombinant
proteins was confirmed by flow cytometry or western blotting.
Stable CHO cell clones capable of tetracycline-inducible
expression of PAR1, talin and kindlin-2 were generated as
described [34].
Figure 1. Model of agonist-induced aIIbb3 activation. (A) Stimulation of a platelet agonist receptor (e.g., PAR1) by an agonist leads to the
activation of Rap1, resulting in targeting of its effector, RIAM, to the plasma membrane. (B) Cell stimulation also releases talin from its auto-inhibitory
state, resulting in separation of the THD from the talin rod domain and recruitment of talin to the membrane-bound Rap1/RIAM complex. (C)
Membrane-bound talin is recruited to aIIbb3 by interaction of the THD with membrane-distal residues in the b3 cytoplasmic domain. (D) Further
interactions of the THD with membrane-proximal b3 tail residues and membrane phospholipids leads to separation of the aIIb and b3 tail and
transmembrane domains, triggering propagated changes in the extracellular domains leading to high-affinity binding of adhesive ligands, such as
fibrinogen. While kindlins, like talin, can interact with the b3 cytoplasmic tail, they can also bind to other proteins [20,42], and the molecular basis of
their integrin co-activating function remains unclear. This working model is based on published studies summarized in [2].
doi:10.1371/journal.pone.0034056.g001
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The sequence of CHO cell kindlin-2 was determined by reverse
transcriptase PCR, and two shRNA sequences were designed as
follows: shRNA1: 59-AAAAAAGTGCACCGCCGGACTCCTC
TCAGCTCTCACAAGCTTCTAAGAGCCGAGAGGAGTCC
AGCGGTACACGTGTTTCGTCCTTTCCACAA-39; shRNA2:
59-AAAAAAGCTA ATCTGCAGACTACCATCCAGCGTAC-
CAAGCTTCGCACACTGGATGGCAGCCTGCAGATTAGC
GGGTTTCGTCCTTTCCACAA-39. These shRNAs and a
control shRNA obtained from a scrambled sequence of mRNA
derived from Rock1 [35] were subcloned into lentiviral vector
FG12 [36]. Depending on the experiment, GFP, DsRed or Tac
was subcloned into FG12 downstream of the UbiC promoter to
subsequently mark transduced cells. CHO cells were transduced
with lentiviruses as described [35].
Integrin activation of transduced cells was assessed by flow
cytometry with antibody PAC-1 [11]. Ninety-six hours after
transduction, cells were incubated for 20 hours with 1 mg/ml
doxycycline (or vehicle) to induce PAR1 and talin expression. Cells
were then incubated for 20 min at room temperature with
100 mM SFLLRN (or vehicle), and specific (EDTA-inhibitable)
PAC-1 binding to single living cells was quantified. To rescue the
effect of the knockdown, cells transduced with kindlin-2 shRNA
were transiently co-transfected with kindlin-2 expression vector
and a transfection marker for 52 hours. Cells were induced with
doxycycline as indicated and specific PAC-1 binding to trans-
duced, transfected cells was quantified.
Protein interactions in living cells determined by
bimolecular fluorescence complementation (BiFC)
Chimeric proteins aIIb-VC (VC: Venus C-terminal moiety) and
VN-talin (VN: Venus N-terminal moiety) used for BiFC
experiments have been described [11]. A VN-kindlin-2 chimera
was produced by PCR, cloned into pCMV and sub-cloned into
pcDNA4/TO for inducible expression in CHO cells [11]. Protein
interactions involving VN-talin or VN-kindlin-2 and aIIb-VCb3
were monitored by BiFC using flow cytometry [11] or deconvolu-
tion microscopy. As specified in each experiment, transfected or
transduced cells were identified by expression of a fluorescent
marker, such as DsRed, or Tac, the latter detected with a
fluorescently-labeled secondary antibody [28]. In all experiments,
BiFC signals were first normalized for aIIbb3 expression detected
with antibody D57 and compared across various experimental
conditions.
For deconvolution microscopy, cells were plated onto fibrino-
gen-coated cover slips for 45 min and fixed by 4% paraformal-
dehyde in PBS for 10 min., stained with antibody D57 to aIIbb3,
and imaged with a deconvolution microscope (DeltaVision,
Applied Precision, Issaquah, WA) using a charged-coupled device
camera system (CoolSNAP HQ; Photometrics, Tucson, AZ)
attached to an inverted wide-field fluorescence microscope (Eclipse
TE200; Nikon, Melville, NY) equipped with 406 oil-immersion
objective (Nikon, Melville, NY)). Identical software settings were
used for image acquisition of all samples in a given experiment,
and images were deconvoluted with an iterative-constrained
algorithm. Cell fluorescence intensity range was standardized
using the Softworks Analysis Program (Applied Precision,
Issaquah, Washington). Any adjustments of color balance made
with Photoshop CS4 software (Adobe Systems, San Jose, CA) were
applied to the entire image in a figure, and no nonlinear
adjustments were made. To examine cell spreading, images were
assessed using ImageJ 1.41o software (National Institutes of
Health, Bethesda, Maryland). Every cell in an image was selected.
Cells that did not express the DsRed transduction marker or were
not completely in the field-of-view were exempted and ‘‘holes’’
inside the cell were removed. Spreading was calculated as total
pixels per cell. The mean pixel count for 50–75 cells for each
treatment was acquired.
To evaluate talin and integrin co-localization by fluorescence
overlay, transduced (DsRed-positive) cells were analyzed using
Metamorph (Molecular Devices, Inc., Sunnyvale, CA). Cell
fluorescence intensity range was standardized for each wavelength
and the same threshold was used for each image. Cell membrane
edges were selected by the ‘‘freehand’’ tool. Using ‘‘region
statistics,’’ integrated intensities for the 525 nm (BiFC) and
684 nm wavelengths (aIIbb3) were acquired for the membrane
edge region, yielding total pixels for BiFC and aIIbb3 (D57)
fluorescence. A ratio describing the amount of BiFC fluorescence
that overlaps the integrin fluorescence was defined as (BiFC
integrated intensity)/(Integrin integrated intensity), and the mean
ratio for 30–60 cells per treatment was calculated.
Protein purification and b3 integrin tail pull-down assay
THD was expressed and purified [17]. Kindlin-3 was expressed
and purified from S2 insect cells. Briefly, S2 insect cells stably
expressing kindlin-3 with Flag and His6 purification tags were
generated by selecting against blasticidin for two weeks. Cells were
cultured, harvested and lysed in TBS buffer (20 mM Tris,
150 mM NaCl, pH 7.4), and kindlin-3 was purified sequentially
with Ni-NTA, anion exchange and size exclusion columns
(Figure S2).
b3 integrin tail pull-down assays were performed as described
[37,38]. Briefly, recombinant b3 tails were captured by Neutra-
vidin beads (Thermo Fisher Scientific, Rockford, IL) and
incubated at 4uC overnight with purified THD and kindlin-3 in
a pull-down buffer (20 mM PIPES, 50 mM NaCl, 150 mM
sucrose, 1 mM Na3VO4, 50 mM NaF, 40 mM Na4P2O7, 0.1%
Triton X-100, pH 6.8). Beads were washed and the bound
fraction was eluted with 16 sodium dodecyl sulfate-polyacryl-
amide gel electrophoresis (SDS-PAGE) loading buffer. Proteins
bound to the b3 tail beads were separated by SDS-PAGE,
transferred to a nitrocellulose membrane and detected by western
blotting with anti-His6 antibody. Protein bands on blots were
quantified with the Odyssey infrared imaging system (Li-Cor
Biosciences, Lincoln, NE).
Plasma membrane isolation
Cells were transfected with HA-talin and GFP-RIAM-(1-176)-
CAAX [13] and subjected to surface biotinylation with 3 mM EZ-
Link Sulfo-NHS-Biotin (Pierce Biotechnology, Inc., Rockford, IL)
dissolved in 0.1 M sodium phosphate buffer, pH 8.0. After 30 min
incubation, cells were extensively washed with phosphate-buffered
saline, pH 7.4, and resuspended on ice for 10 min in fractionation
buffer (20 mM HEPES-KOH pH 7.5, 1.5 mM MgCl2,5m M
KCl, 0.2 mM Na3VO4,1 0mg/mL leupeptin, 10 mg/mL aproti-
nin, 1 mM phenylmethanesulfonylfluoride, and Complete mini
protease inhibitor tablet (Roche Applied Bioscience, Indianapolis,
IN)). Swollen cells were disrupted by passing through a 27G
needle. The resulting mixture was centrifuged at 2000 rpm for
10 min to pellet nuclei and unbroken cells. The supernatant was
further centrifuged at 14,000 rpm for 30 min to pellet the
membrane fraction. The supernatant was saved as the ‘‘cytosolic’’
fraction.
Pelleted crude membranes were resuspended in fractionation
buffer and incubated with BcMag
TM Streptavidin Magnetic Beads
(Bioclone Inc, San Diego, CA) for an hour at room temperature
with rotation to obtain bound plasma membranes. After washing
the beads, bound proteins were eluted with SDS sample buffer,
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membrane. The amounts of HA-talin and GFP-RIAM-(1-176)-
CAAX in whole cell lysates, nuclear/intact cell, cytosolic, crude
membrane, and plasma membrane fractions were analyzed by
western blotting using anti-HA and anti-GFP antibodies, respec-
tively. Antibodies to aIIb, calnexin, and RhoGDI were used as
plasma membrane, ER membrane, and cytosolic markers,
respectively. Bands corresponding to talin and aIIb in the whole
cell lysates and in the plasma membrane fraction were scanned
and quantified with the Odyssey imaging system. Talin detected in
the plasma membrane fraction was normalized to the total amount
in whole cell lysate and designated as ‘‘percent of total’’. Since
there might be variations in the efficiency of plasma membrane
recovery for different cell preparations, the percent of total for
talin was further normalized by the percent of total for aIIb, which
as an integral membrane protein represents maximum possible
plasma membrane recovery.
Western blotting
Cells were lysed with NP-40 lysis buffer (50 mM Tris-HCl,
pH 7.4, 1% NP-40, 150 mM NaCl, 1 mM NaF, 0.5 mM sodium
vanadate, 12.5 mg/ml leupeptin, and Complete, EDTA free
(Roche, Indianapolis, IN)). After clarification, lysates were
subjected to SDS-PAGE, transferred to nitrocellulose membranes
and analyzed by western blotting.
Results and Discussion
aIIbb3 activation in platelets is regulated by signaling pathways
downstream of plasma membrane receptors, many of them G-
protein-coupled [39]. Agonist peptide, SFLLRN [26], stimulates
the human PAR1 thrombin receptor, a prototype agonist receptor
. In order to study relationships between kindlins, talin and
aIIbb3, we turned to a CHO cell model system in which specific
proteins can be silenced with shRNAs or expressed in a
tetracycline-regulated manner, and aIIbb3 activation can be
monitored by flow cytometry using activation-specific antibody
PAC-1. This model system exhibits talin-dependent aIIbb3
activation in response to SFLLRN and over-expression of
activated Rap1 and/or its effector, RIAM [11,12]. Furthermore,
over-expression of kindlin-2 enhances talin-induced aIIbb3
activation in these CHO cells [21]. Thus, this CHO cell model
has been employed to study inside-out integrin signaling through
talin and RIAM with results consistent with those obtained from
platelets and megakaryocytes [11].
First, we designed kindlin-2 shRNAs and performed preliminary
experiments to characterize the kindlin-2 lentiviral shRNA
constructs. We observed greater than 90% knockdown of
kindlin-2 in the shRNA-transduced cells (Figure S1). Next we
asked whether endogenous kindlin-2 is required for SFLLRN-
induced aIIbb3 activation. CHO cells stably expressing aIIbb3
and conditionally-expressing PAR1 and full-length talin in
response to doxycycline [11] were transduced with lentiviruses
expressing either a kindlin-2 shRNA or a scrambled, control
shRNA. PAC-1 binding to the transduced (GFP-positive) cells was
analyzed by flow cytometry [11]. In the absence of doxycycline,
cells transduced with control shRNA exhibited a relatively low
level of PAC-1 binding, whether or not they had been stimulated
with SFLLRN (Figure 2A). However, after induction of PAR1 and
full-length talin with doxycycline, the cells exhibited higher basal
PAC-1 binding, and significantly more PAC-1 binding in response
to 100 mM SFLLRN (P,0.01) (Figure 2A). By contrast, cells
transduced with either of two kindlin-2 shRNAs and incubated with
doxycycline showed less basal PAC-1 binding, and no enhanced
PAC-1 binding in response to SFLLRN (Figure 2A). Thus, the
silencing of endogenous kindlin-2 abolishes agonist-induced aIIbb3
activation. The inhibitory effect of kindlin-2 knockdown on aIIbb3
activation could not be explained by off-target effects on
expression levels of talin (Figure 2B) or PAR1 (not shown), and
the specificity of kindlin-2 knockdown was supported by the
observation that co-expression of a shRNA-resistant form of
kindlin-2 cDNA rescued the reduced integrin activation
(Figure 2A,B). Thus, re-introducing kindlin-2 into the cell restores
the increase in PAC-1 binding in response to SFLLRN (P,0.01).
In contrast to its inhibitory effect on aIIbb3 activation by talin,
kindlin-2 knockdown had no effect on PAC-1 binding when
recombinant THD was introduced into the CHO cells (Figure 2C).
Previous work by others [21], which has been discussed in recent
reviews [20,40], showed a modest decrease in THD-induced
integrin activation when kindlin-2 was depleted [21]. In contrast,
we saw no statistically significant effect. Our results are consistent
with previous findings that THD can activate aIIbb3 mutants with
markedly reduced affinity for kindlins [17,41]. Our results also
agree with the observation that THD alone is sufficient to activate
integrins reconstituted in lipid bilayers [17]. Importantly, the same
degree of kindlin-2 depletion reduced integrin activation mediated
by full length talin (Figure 2). Thus as for kindlin-3 in platelets
[18], kindlin-2 in CHO cells is required for aIIbb3 activation in
response to PAR1-mediated, talin-dependent inside-out signaling.
That said, loss of kindlin or kindlin-integrin interaction only has a
modest effect at best on activation of aIIbb3 by THD [17,21,41].
These results could in principle be explained by a role for
kindlin-2 in one or more steps of the inside-out aIIbb3 signaling
pathway illustrated in Figure 1. Kindlins contain a PH domain
interposed between a split F2 subdomain within the integrin-
binding FERM domain [42]. Since the PH domain may promote
kindlin interactions with membrane phosphoinositides [43], we
wondered if kindlins played a role in targeting of full-length talin to
the plasma membrane. A role for the kindlin-2 PH domain in
integrin function is supported by observations that deletion of this
domain reduces b3 integrin adhesive function in CHO cells [21],
whereas mutation of the PH domain abrogates kindlin-2 binding
to phosphoinositides, particularly PIP3, and reduces b1 and b3
integrin activation and function in podocytes [44]. To determine
whether kindlin-2 promotes talin recruitment to plasma mem-
branes, aIIbb3-CHO cells were surface-biotinylated, transduced
with control or kindlin-2 shRNA, and transfected with full-length
talin and THD. Since cells transduced with kindlin-2 shRNA2
grow slowly, we focused on shRNA1 transduced cells in order to
consistently obtain sufficient number of cells for these experiments.
Cells co-transfected with full-length talin and RIAM-(1-176)-
CAAX, which targets talin to cell membranes [13], were used as
positive controls for increased membrane recruitment. Cell plasma
membranes were affinity-isolated using streptavidin, and the
amount of associated talin was quantified by western blotting.
Co-expression of aIIb and b3 subunits results in efficient surface
expression of integrin aIIbb3 [45]. Fluorescence images of aIIbb3-
expressing CHO cells in this work (see below) and others [12]
verify that the majority of this integrin is at the cell surface.
Furthermore, western blotting of whole cell lysates showed that
aIIbb3 expression levels were similar between the control cells and
kindlin-2 knockdown cells when the loading control, endogenous
RhoGDI [46,47], was comparable (Figure 3B). Thus recovery of
aIIb, an integral membrane protein, in the plasma membrane
fraction was set as a reference for maximal plasma membrane
recovery, and recovery of full-length talin or THD with plasma
membranes was normalized to that of aIIb. RIAM-(1-176)-CAAX
increased the abundance of full-length in plasma membranes
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PLoS ONE | www.plosone.org 4 March 2012 | Volume 7 | Issue 3 | e34056Figure 2. Kindlin-2 requirement for talin-dependent, agonist-induced aIIbb3 activation in CHO cells. (A) Agonist-induced PAC-1 binding
determined in kindlin-2 knockdown cells. aIIbb3 CHO cells engineered to conditionally express PAR1 and talin were transduced with lentivirus
encoding control (Ctrl) or kindlin-2 shRNAs as described in Experimental Procedures. Cells were incubated for 20 min at room temperature with
100 mM SFLLRN (or vehicle), and specific PAC-1 binding was quantified by flow cytometry as described [11]. To control for off target effects of knock-
down constructs, shRNA-transduced cells were transiently co-transfected with an shRNA-resistant form of Flag-kindlin-2 (or empty vector, Mock) and
Tac as a transfection marker. After induction of PAR1 and talin with doxycycline, specific PAC-1 binding was measured and normalized to integrin
expression as determined by D57 staining. For clarity, data are expressed as the fold-increase in PAC-1 binding relative to binding observed with
doxycycline-induced cells transduced with control shRNA. Data represent means 6 SEM of six independent experiments (asterisk, P,0.01). (B)
western blots were performed to assess expression of talin and kindlin-2 in lysates of cells studied in panel A. b-actin was monitored as a loading
control. In the kindlin-2 rescue experiments, kindlin-2 was assessed both with an antibody to kindlin-2 and an antibody to the Flag epitope. The cell
lysates were from both uninfected and virus transduced cells whereas using flow cytometry gating, only virus transduced cells were analyzed in panel
A. (C) Kindlin-2 shRNA has no effect on PAC-1 binding induced by THD. aIIbb3 CHO cells were transduced with lentivirus encoding kindlin-2 (or
control) shRNA. Cells were transfected as indicated with THD, empty vector (Mock) and DsRed. PAC-1 binding to transfected cells was quantified by
flow cytometry. PAC1 binding was normalized to PAC1 binding when integrins are fully activated by an activating antibody, which also is sensitive to
the integrin expression level [28]. For clarity, data are expressed as the fold-increase in PAC-1 binding relative to binding observed with THD
transfected/control shRNA transduced cells. Data represent means 6 SEM of 7 experiments. (Asterisk, P,0.01 against mock transfected/control
shRNA transduced cells).
doi:10.1371/journal.pone.0034056.g002
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knockdown had no effect on the recovery of talin or THD within
the plasma membrane fraction (Figure 3A,B). These results suggest
that kindlin-2 is not required for the regulated targeting of talin to
plasma membranes.
Since talin recruitment to membranes may be necessary but not
sufficient for talin recruitment to aIIbb3 (Figure 1), we employed
bimolecular fluorescence complementation [48,49] to evaluate
whether kindlins promote talin recruitment to the integrin [11].
The principle of BiFC for studies of talin recruitment is illustrated
in Figure 4A. For these experiments, the C-terminal half of Venus
fluorescent protein was fused to the C-terminus of aIIb and this
fusion protein was stably expressed in CHO cells with b3( aIIb-
VCb3 CHO cells). The N-terminal half of Venus was fused to the
N-terminus of talin and VN-talin was expressed conditionally in
aIIb-VCb3 CHO cells in response to doxycycline. When VN-talin
Figure 3. Effect of kindlin-2 knockdown on talin recruitment to the membrane. (A) aIIbb3 CHO cells were transduced with lentivirus
encoding either control shRNA or kindlin-2 shRNA. Cells were then transfected as indicated with THD, talin, or talin and RIAM1-176CAAX. Intact cells
were surface biotinylated in order to isolate membrane-bound proteins. Cells were broken-up by shear and then underwent serial centrifugation to
isolate the nuclear/intact cell fraction, cytosolic fraction and crude membranes. The crude membranes were further purified with streptavidin
conjugated beads. The streptavidin bound material was isolated as the plasma membrane fraction. The amount of THD and talin in each fraction as
well as in whole cell lysate (WCL) was quantified by western blot. Data is expressed as relative protein recovery normalized to the recovery of integrin
aIIb subunit in plasma membrane. Data represent means 6 SEM of three independent experiments (asterisk, P,0.10 in paired t-test). (B)
Representative western blots of the subcellular fractionation experiments showing the WCL and plasma membrane fraction. Western blot of the WCL
showed that aIIb expression levels are unchanged. RhoGDI serve both as a loading control [46,47] and a cytosolic marker. Western blots of each
target proteins and markers were cut and juxtaposed for clarity. The complete blot images with all the subcellular fractions are shown in Figure S3.
doi:10.1371/journal.pone.0034056.g003
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PLoS ONE | www.plosone.org 6 March 2012 | Volume 7 | Issue 3 | e34056Figure 4. Effect of kindlin over-expression or depletion on talin interaction with aIIbb3 in living cells and in vitro. (A) Schematic
illustration of BiFC in CHO cells depicting aIIb-VC, VN-talin, and b3. When VN-talin interacts with aIIb-VCb3 through the b3 tail, VN and VC should
reconstitute the Venus fluorophore, resulting in BiFC [11]. (B) Neither over-expression nor knock-down of kindlins promote talin interaction with
aIIbb3. aIIb-VCb3 CHO cells (or cells expressing mutant aIIb-VCb3D724) were co-transfected with an expression vector for Flag-kindlin-2, Flag-kindlin-
3, or empty vector (Mock) along with Tac as a transfection marker. To assess the effects of kindlin-2 knockdown, aIIb-VCb3 CHO cells were transduced
with kindlin-2 shRNA1 (or control shRNA, Mock). VN-talin expression was induced with doxycycline, and BiFC was quantified by flow cytometry. BiFC
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together, re-fold and generate fluorophore detectable by flow
cytometry or microscopy. To control for fluorescence due to ‘‘non-
specific’’ Venus self-association independent of talin interaction
with b3 [50], parallel experiments were carried out with aIIb-
VCb3D724 CHO cells, in which the b3 tail had been truncated to
delete residues necessary for initial interactions with talin and
kindlins [11]. To control for potential differences in aIIbb3
expressions, BiFC signals were first normalized to aIIbb3
expression levels, as measured with an anti-aIIbb3 antibody
(D57), and then compared for each experimental condition.
Before treatment with doxycycline, aIIb-VCb3 CHO cells
exhibited a basal level of Venus fluorescence, likely due to leaky
expression of VN-talin (Figure 4B). After induction of VN-talin
expression with doxycycline, BiFC increased significantly in the
aIIb-VCb3 CHO cells (P,0.01) but not in the aIIb-VCb3D724
CHO cells (Figure 4B). Furthermore, transient over-expression of
kindlin-2 in the aIIb-VCb3 CHO cells failed to increase BiFC
further; rather, a small decrease was observed. A small but
statistically significant decrease in BiFC was also obtained when
kindlin-3 was over-expressed (P,0.05) (Figure 4B). Since kindlin
over-expression did not affect VN-talin expression (Figure 4C),
these results suggest that kindlins do not promote the interaction of
talin with aIIbb3 in CHO cells, despite the fact that kindlin-2
promotes talin-dependent aIIbb3 activation (Figure 2) [21]. This
conclusion is tempered by the possibility that endogenous kindlin-2
in the cells may be sufficient to promote talin recruitment to b3.
To examine this possibility, aIIb-VCb3 CHO cells were
transduced with a kindlin-2 (or control) shRNA, and VN-talin
expression was induced with doxycycline. Although knockdown of
kindlin-2 was efficient (Figure 4C) and caused a decrease in PAC-1
binding (Figure 4D) qualitatively similar to our previous result
obtained in a different cell clone (Figure 2A), it had no effect on
the interaction between VN-talin and aIIb-VCb3 (Figure 4B),
indicating that talin recruitment to aIIbb3 in CHO cells does not
require the presence of kindlin. Although over-expressed kindlins
inhibited talin-integrin interactions, endogenous kindlin might not
be sufficient to block talin binding. This could account for the
failure of kindlin knockdown to increase talin-integrin BiFC.
Since BiFC experiments require Venus fusion proteins, it could
be argued that the above results do not reflect the influence of
kindlin-2 on the behavior of native talin or aIIbb3. Therefore,
these observations were extended to purified, recombinant
proteins. We used recombinant kindlin-3 (Figure S2), the
hematopoietic isoform that is physiologically relevant to integrin
aIIbb3 regulation and has 53% identity and 72% similarity to
kindlin-2, for the in vitro experiments. When talin or THD, the
integrin fragment of talin that activates integrins, was incubated
with beads coated with recombinant b3 cytoplasmic tail, it bound
to the beads as expected [51]. Moreover, increasing amounts of b3
tail-bound kindlin-3 failed to promote either talin or THD binding
to the b3 tail (Figure 4E,F). In fact, kindlin appears to inhibit the
binding of talin but not THD (Figure 4E,F), to b3 tails, suggesting
that the inhibitory effects might be a result of steric hindrance.
This result is consistent with the inhibitory effects of kindlins on
talin recruitment to aIIbb3 we observed in the BiFC studies
(Figure 4B). Thus, we conclude that kindlins do not promote talin
interaction with aIIbb3, either in CHO cells or in a purified
system.
To visualize the cellular location of the BiFC signals, aIIb-
VCb3 CHO cells were plated on fibrinogen for 45 min to allow
cell spreading, and cells were examined by fluorescence micros-
copy. As expected, induction of VN-talin expression increased cell
spreading, whereas kindlin-2 knockdown reduced cell spreading
(P,0.01) (Figure 5A,B). Despite this, kindlin-2 knockdown had no
effect on the intensity of BiFC signals co-localizing with antibody-
stained aIIbb3 at the plasma membrane, consistent with our
subcellular fractionation results (Figure 5A,C). Although cell
spreading is significantly reduced in kindlin-2 knock-down cells,
cell spreading increased in these cells in response to induction of
VN-talin expression. This could be a result of increased aIIb-
VCb3 and VN-talin interaction due to basal VN-VC self-
complementation. Alternatively, we speculate that kindlin-depen-
dency of cell spreading (outside-in-signaling) and integrin activa-
tion (inside-out signaling) may differ.
Although the PH domain and positively charged motifs in the
F1 domain of kindlins facilitate targeting to membrane phospho-
inositides [44,52,53], mechanisms regulating the interaction of
kindlins with integrin cytoplasmic tails remain to be fully
characterized. We modified the BiFC method to ask whether the
interaction of kindlins with the b3 cytoplasmic tail is influenced by
talin binding to b3 (Figure 6A). VN-kindlin-2 was expressed
conditionally in aIIb-VCb3 CHO cells and BiFC was studied by
flow cytometry. Preliminary experiments established that VN-
kindlin-2 was functional in that it promoted talin-dependent PAC-
1 binding to doxycycline-treated aIIb-VCb3 CHO cells (not
shown). Induction of VN-kindlin-2 expression in these cells caused
a significant increase in BiFC fluorescence to a much greater
extent than in aIIb-VCb3D724 CHO cells, showing that
VN-kindlin-2 and aIIb-VCb3 interaction requires the b3
cytoplasmic domain (Figure 6B). However, over-expression of
either THD or full-length talin failed to increase the interaction
between kindlin-2 and aIIb-VCb3 (Figure 6B,C). On the contrary,
over-expression of THD inhibited BiFC between VN-kindlin-2
and aIIb-VCb3 (Figure 6B). Studies with native, recombinant
proteins in vitro demonstrated that increasing concentrations of
THD had no effect on the binding of kindlin-3 to the b3
cytoplasmic tail (Figure 6D). The reason for this discrepancy, we
speculate, is that in cells integrin activation by THD results in
other signaling factors or signaling complexes being recruited
to integrin tails, which might then affect kindlin-integrin
interaction. Consistent with our previous observation that
fluorescence was normalized to aIIbb3 expression and presented as fold-increase relative to doxycycline-induced, mock-treated cells. Data represent
means 6 SEM of three experiments (asterisk denotes statistically significant difference against mock/induced, P,0.05). (C) Western blots were
performed to monitor expression of talin and kindlins in lysates of aIIb-VCb3 CHO cells studied in panel B. Left side: western blot of WCL showed
successful expression of kindlin-2, kindlin-3 and VN-talin. Right side: Western blots of WCL showed successful knockdown of kindlin-2 by shRNA1,
without effects on VN-talin expression. (D) Kindlin-2 knockdown decreased basal PAC-1 binding as expected (asterisk, P,0.01). (E) Purified talin with
or without addition of kindlin-3 was incubated with the recombinant b3 cytoplasmic tails conjugated to neutravidin beads as described in
Experimental Procedures. After washing, proteins bound to the beads were detected on western blots. Band intensities were quantified in LICOR,
normalized to talin binding in the absence of kinldin-3, and presented as a curve. Insert shows a representative western blot of 3 independent
experiments. Increasing amounts of b3 tail-bound kindlin-3 failed to promote b3–talin interaction. Data represent means 6 SEM of three
experiments. (F) Same as (E) but purified THD was used instead of talin. Increasing amount of b3 tail-bound kindlin-3 failed to promote b3–THD
interaction. Blots were performed with anti-talin (8d4) for talin, anti-flag and anti-His6 for kindlin-3 and THD. b3 tail loading was visualized by
Coomassie stain. (asterisks in E and F denote statistically significant differences compared to talin or THD binding in the absence of kindlin-3, P,0.05).
doi:10.1371/journal.pone.0034056.g004
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the b3 tail (Figure 4F), recombinant talin also inhibited kindlin-3
and b3 tail interaction (Figure 6E). However, over-expression of
talin in CHO cells did not inhibit BiFC between VN-kindlin2 and
aIIb-VCb3 (Figure 6B), possibly because only a small fraction of
over-expressed talin was targeted to the plasma membrane
Figure 5. Subcellular localization of BiFC signals. aIIb-VCb3 CHO cells were transduced with kindlin-2 (or control) shRNA lentiviruses also
encoding DsRed, and VN-talin was induced by doxycycline. (A) Cells were incubated on fibrinogen-coated plates (100 mg/ml coating concentration)
for 45 min, fixed, stained with antibody D57 for aIIbb3, and examined by deconvolution microscopy (BiFC: Green, aIIbb3: blue, Transduced: red). The
arrows point to transduced cells, and the arrowhead to a non-transduced cell. (B) Spreading of transduced cells was examined and data were
expressed as mean cell surface areas measured in total pixels as described in Experimental Procedures. Asterisk denotes statistically significant
difference against respective control cells, P,0.01 (C) BiFC and aIIbb3 fluorescence co-localization in transduced cells was evaluated by
deconvolution microscopy as described in Experimental Procedures. Data represent 30–60 cells analyzed for each treatment. (D) Western blots were
performed to monitor expression of talin and kindlin-2 in cell lysates. The cell lysates were from both uninfected and virus transduced cells whereas
only virus transduced cells were analyzed in (A), (B) and (C).
doi:10.1371/journal.pone.0034056.g005
Kindlins in Integrin aIIbb3 Activation
PLoS ONE | www.plosone.org 9 March 2012 | Volume 7 | Issue 3 | e34056Figure 6. Effect of talin or THD on interaction between kindlins and aIIbb3. (A) Schematic illustration of BiFC in CHO cells depicting aIIb-VC,
VN-kindlin-2 and b3. When VN-kindlin interacts with aIIb-VCb3 through the b3 tail, VN and VC should reconstitute Venus, resulting in BiFC. (B) Over-
expression of THD or talin does not promote kindlin-2 interaction with aIIbb3. CHO cells expressing aIIb-VCb3o raIIb-VCb3D724 was co-transfected
with Tac as a transfection marker and an expression vector for THD, talin or empty vector (Mock), as indicated. After induction of VN-kindlin-2
expression with doxycycline, BiFC was quantified by flow cytometry. BiFC fluorescence was normalized to aIIbb3 expression and expressed as fold-
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kindlin interaction with integrin b3.
In conclusion, the present studies in CHO cells and in purified
systems suggest that kindlins and talin do not promote each other’s
bulk interactions with integrin b3. Whereas it is not currently
feasible to conduct similar studies in platelets, we speculate that
kindlins might co-activate aIIbb3 in platelets by participating in
events other than initial talin recruitment to integrin aIIbb3. THD
is sufficient to activate aIIbb3 in model membranes in purified
systems [17] and can activate the integrins in cells when the
integrins’ kindlin binding site is mutated or endogenous kindlin is
silenced. Yet kindlins further promote talin-dependent aIIbb3
activation in cells [18,21,22]. Consequently, a fundamental
question remains as to how the kindlins function as aIIbb3 co-
activators if they do not promote talin targeting to membranes or
to the integrin itself. A related question is why the integrin co-
activating functions of kindlin-2 and kindlin-3 are cell-type and
integrin-specific [21,22,54]. Based on the present studies, we
suggest that talin and kindlin synergize in integrin activation not
by altering the interaction of each other with the integrins. Thus,
kindlins may co-activate aIIbb3 by modifying events that take
place after initial talin recruitment (Figure 1). Such events might
include 1) post-translational or structural changes in talin or
aIIbb3that promote talin interactions with membrane-proximal
residues in the b3 tail or with membrane phospholipids; 2)
displacement of a negative regulator of integrin signaling that
competes with talin for critical interactions with aIIbb3; or 3)
interaction of talin and kindlins together with as yet unidentified
factor(s) to promote integrin activation [2,20,42].
Supporting Information
Figure S1 kindlin-2 shRNA can achieve efficient kindlin-
2 knockdown in CHO cells. Integrin expressing CHO cells
were transduced with lentivirus encoding control or kindlin-2
shRNAs as described in Experimental Procedures. 96 hours later
the cells were analyzed by western blotting to determine the
efficiency of kindlin-2 knockdown (A) and by FACS to determine
the percentage of lentivirus transduced cells (GFP positive) (B).
Numbers in (A) indicates kindlin-2 band intensity. Kindlin-2
shRNA1 achieved 83% kindlin-2 depletion with 92% infection
rate, indicating that shRNA1 transduced cells on average lost 90%
of kindlin-2 expression. ShRNA2 resulted in 65% depletion with
65% infection rate, indicating that shRNA2 transduced cells lost
virtually all of their kindlin-2 expression. The lane of shRNA2 was
excised from the same blot image and was juxtaposed to the other
two lanes for clarity. Monoclonal anti-kindlin-2 from Dr. Wu
(University of Pittsburg) was used for kindlin-2 detection.
(TIF)
Figure S2 Characterization of recombinant kindlin3.
Biophysical and biochemical assays indicated that recombinant
kindlin-3 was monomeric and folded. (A) Size exclusion chroma-
tography of purified kindlin-3 compared to molecular standards.
(B) Coomassie Brilliant Blue staining of purified kindlin-3, showing
a major band consistent with the theoretical molecular size of the
kindlin-3 construct, 76.9 kDa. (C) Plot of the Stokes radius of the
standard against (2Log((Ve-Vo)/(Vc-Vo)))(1/2), where Ve repre-
sents retention volume, Vo represents void volume, and Vc
represents column volume. Stokes radii used for the standard
proteins were: thyroglobulin 8.5 nm, apoferritin 6.1 nm, b-
Amylase 5.4 nm, albumin 3.55 nm, and carbonic anhydrase
2.01 nm. The calculated Stokes radius for kindlin-3 is ,3.8 nm,
and the kindlin-3 chromatogram is consistent with a molecular
weight of 91.6 kDa, assuming kindlin-3 is a globular protein
similar to the standards. (D) Differential scanning calorimetry
showing two peaks indicating that recombinant kindlin-3 is folded.
It is likely that the first peak is the melting of the protein tertiary
structure and the second peak the melting of a stable secondary
structure or structural domain.
(TIF)
Figure S3 Representative western blots of the subcellu-
lar fractionation experiments. WCL, nuclei and unbroken
cells, cytosolic fraction, crude membrane fraction and plasma
membrane fraction were resolved by SDS-PAGE, transferred to
nitrocellulose membrane, and blotted by anti-kindlin-2, anti-talin,
anti-HA, anti-aIIb. Calnexin as an endoplasmic reticulum marker
and RhoGDI as a cytosolic marker and loading control were also
blotted to assess the purity of the plasma membrane preparation.
(TIF)
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